Becton Dickinson plans to sell its surgical devices business and three manufacturing plants as part of a divestment planned for the end of 2023.
Steris, an Ireland-based medical devices company, will buy Becton Dickinson's surgical products business for $540 million, which includes manufacturing sites in St. Louis, Cleveland and Tuttlingen, Germany, according to a June 20 news release.
"Divesting the platform advances [... the company's] 2025 strategy and is an important step in simplifying BD's product portfolio and manufacturing network," the release said.